Home Search

Stem cell gene therapy - search results

If you're not happy with the results, please do another search
cannabinoids and health

Cannabinoids and health – from supplements to medicines

GreenLight Medicines is a supplier of quality supplements and is an active MedCan research company GreenLight, Supplements and Medicines.
intramembrane proteases

What is the role of intramembrane proteases in Cancer?

Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
imaging and spectroscopy

Cardiovascular magnetic resonance imaging and spectroscopy

Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.
treatment of ovarian cancer

Welsh project aims to offer treatment as ovarian cancer cases continue to rise

A new £2.6 million project led by Swansea University Medical School aims to dramatically improve the diagnosis and treatment of ovarian cancer.
prevention of type 1 diabetes

Turning a corner in the prevention of Type 1 diabetes

Dr Elizabeth Robertson, Director of Research at Diabetes UK explains why 2019 marked turning a corner in the prevention of Type 1 diabetes but adds that there is still more research to be done in this area.
vessel growth

Vessel growth in health and disease

John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
mitochondrial-lysosomal, diabetic retinopathy

The role of TXNIP in mitochondrial-lysosomal axis dysregulation

Lalit P. Singh, Associate Professor at Wayne State University School of Medicine, explains the role of TXNIP in mitochondrial-lysosomal axis dysregulation in diabetic retinopathy.
cost-effectiveness

Precision medicine: Cost-effectiveness of breakthrough treatments

Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
NHS technology

Government to invest over £130 million in new NHS technology

Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.
clinical contact research

Clinical Contract Research: Building the digital bridge between clinical research and clinical care

Prof Dr Freimut Schliess, Director, Science & Innovation at Profil GmbH, sheds light on how Clinical Contract Research Organisations are building the digital bridge connecting clinical research and clinical care.
chronic autoimmune uveitis, ophthalmology

Understanding chronic autoimmune uveitis through ophthalmology research

Andrew Taylor, Professor of Ophthalmology, highlights research to understand the molecules that mediate ocular immune privilege so they can be adapted for chronic autoimmune uveitis.
infection prevention

Infection prevention: Overcoming challenges in sepsis diagnosis

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group discusses the concerns with overcoming challenges in sepsis diagnosis.
medicinal benefits of CBD

The medicinal benefits of CBD oil and medical cannabis

Here we provide a brief introduction to the medical benefits of CBD and medical Cannabis, with an overview of treatments that have been implemented.
Type 1 diabetes treatment

Charities renew investment in Type 1 diabetes treatment

Diabetes UK and JDRF have announced their continued commitment to revolutionising Type 1 diabetes treatment, by awarding £490,000 to fund the next generation of immunotherapy research.
health and wealth

Delivering improved health and wealth in the UK

Jane Kinghorn, Director of the Translational Research Office at UCL, discusses the importance of research and partnership in improving the health and wealth of the UK.
chronic care

A life- and disease course approach to health protection and chronic care

Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
magnetic resonance imaging

Cardiovascular magnetic resonance imaging and spectroscopy in animal care

Professor Ulrich Flögel explores how magnetic resonance techniques can be used for basic research into animal care in this report.
Acute promyelocytic leukemia

Opportunities and solutions for acute promyelocytic leukaemia (APL)

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group gives an overall perspective on the challenges and concerns around acute promyelocytic leukaemia (APL), a type of blood cancer.
brain tumour

Insights into the mechanisms of primary brain tumour invasion

Thomas Daubon, Clotilde Billottet and Andreas Bikfalvi at the Angiogenesis and Tumor Microenvironment-INSERM U1029, Université Bordeaux provide insights into the mechanisms of primary brain tumour invasion.
deafness, communication disorders

U.S. research on deafness and communication disorders

The National Institute on Deafness and Other Communication Disorders charts the work of their organisation over the last 30 years that concerns research around the communication sciences, including deafness.

Follow Us

Advertisements